InvestSMART

Cyclopharm Limited (ASX: CYC) - Announcements

Current share price for CYC : $0.425 0.04 (10.39%)+

ASX company news and announcements for Cyclopharm Limited (CYC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cyclopharm Limited (CYC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cyclopharm Limited (CYC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cyclopharm Limited (CYC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$53 Application for quotation of securities - CYC 24 Mar 2023 11:44AM $1.450 $0.425 fallen by 70.69%
$53 Date of Annual General Meeting 15 Mar 2023 8:10AM $1.450 $0.425 fallen by 70.69%
$53 CYC Results Summary 20 Feb 2023 2:18PM $1.550 $0.425 fallen by 72.58%
$53 Preliminary Final Report 20 Feb 2023 2:13PM $1.550 $0.425 fallen by 72.58%
$53 Dividend/Distribution - CYC 20 Feb 2023 2:08PM $1.550 $0.425 fallen by 72.58%
$53 Change of Director's Interest Notice - KBarrow 5 Dec 2022 8:22AM $1.375 $0.425 fallen by 69.09%
$53 Change of Director's Interest Notice - DAngus 30 Nov 2022 4:14PM $1.320 $0.425 fallen by 67.80%
$53 Cyclopharm Receives $1.64m R&D Refund 29 Nov 2022 10:44AM $1.365 $0.425 fallen by 68.86%
$53 Bell Potter Healthcare Conference Directors Profile 9 Nov 2022 9:27AM $1.260 $0.425 fallen by 66.27%
$53 Bell Potter Healthcare Conference 9 Nov 2022 8:33AM $1.260 $0.425 fallen by 66.27%
$53 Notification of cessation of securities - CYC 5 Oct 2022 4:09PM $1.400 $0.425 fallen by 69.64%
$53 CYC Board Changes 27 Sep 2022 9:10AM $1.300 $0.425 fallen by 67.31%
$53 Initial Director's Interest Notice 27 Sep 2022 9:09AM $1.300 $0.425 fallen by 67.31%
$53 Initial Director's Interest Notice 1 Sep 2022 7:59AM $1.420 $0.425 fallen by 70.07%
$53 CYC Board Changes 1 Sep 2022 7:59AM $1.420 $0.425 fallen by 70.07%
$53 Half Year 2022 Results 17 Aug 2022 8:17AM $1.450 $0.425 fallen by 70.69%
$53 Half Yearly Report and Accounts 17 Aug 2022 8:14AM $1.450 $0.425 fallen by 70.69%
$53 Dividend/Distribution - CYC 17 Aug 2022 8:14AM $1.450 $0.425 fallen by 70.69%
$53 Technegas Used In Multicenter COVID Study 7 Jul 2022 8:54AM $1.400 $0.425 fallen by 69.64%
$53 1H 2022 Business Update - Record Revenues 4 Jul 2022 10:34AM $1.015 $0.425 fallen by 58.13%
$53 Change of Director's Interest Notice 14 Jun 2022 1:38PM $1.120 $0.425 fallen by 62.05%
$53 CYC Investor Presentation 24 May 2022 24 May 2022 9:35AM $1.300 $0.425 fallen by 67.31%
$53 Technegas used in Diagnosing Long COVID 24 May 2022 8:58AM $1.300 $0.425 fallen by 67.31%
$53 Change of Director's Interest Notice 23 May 2022 8:19AM $1.300 $0.425 fallen by 67.31%
$53 Results of Meeting 17 May 2022 1:13PM $1.310 $0.425 fallen by 67.56%

201 - 225 of 617 results

Page 9 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.